CFH and atypical hemolytic-uremic syndrome: In patients with anti-complement factor H autoantibody-associated atypical hemolytic uremic syndrome (aHUS), these autoantibodies impair complement factor H normal regulatory function in the blood, leading to excessive complement activation on the endothelial surface.